Kia Announces May 2025 Global Sales Results
May 2025 global sales of 269,148 units, up 1.7% Y/yOutside of Korea,…
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor,…
